Metabolic flexibility and reverse remodelling of the failing human heart.
Green PG. et al, (2025), Eur Heart J
Inflammatory cardiovascular events and coronary artery disease – Authors' reply
Chan K. et al, (2025), The Lancet, 405, 545 - 546
Myocardial ischaemia following COVID-19: a cardiovascular magnetic resonance study.
Arnold JR. et al, (2025), Int J Cardiovasc Imaging, 41, 247 - 256
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.
Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26
Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.
Ashkir Z. et al, (2025), Eur Heart J Cardiovasc Imaging, 26, 218 - 228
Quantitative susceptibility mapping at 7 T in COVID-19: brainstem effects and outcome associations.
Rua C. et al, (2024), Brain, 147, 4121 - 4130
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID
Finnigan LEM. et al, (2024), Radiology, 313
1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID.
Finnigan LEM. et al, (2024), Radiology, 313
Etiology and Phenotypes of Cardiomyopathy in Southern Africa: The IMHOTEP Multicenter Pilot Study.
Kraus SM. et al, (2024), JACC Adv, 3
Protein Biomarkers of Adverse Clinical Features and Events in Sarcomeric Hypertrophic Cardiomyopathy.
Tahir UA. et al, (2024), Circ Heart Fail, 17
Effects of software on myocardial T1 measurements: a 3 T multicentre single vendor phantom study
Atkinson D. et al, (2024)
Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study.
Samat AHA. et al, (2024), Int J Cardiol, 415
Exploring cardiovascular involvement in IgG4-related disease: a case series approach with cardiovascular magnetic resonance.
Henry JA. et al, (2024), Heart
Cardiac function and energetics in mice with combined genetic augmentation of creatine and creatine kinase activity.
Zervou S. et al, (2024), J Mol Cell Cardiol, 196, 105 - 114
Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.
Shiwani H. et al, (2024), JACC Cardiovasc Imaging, 17, 1320 - 1331
Hyperpolarized 13C and 31P MRS detects differences in cardiac energetics, metabolism, and function in obesity, and responses following treatment.
Lewis AJM. et al, (2024), NMR Biomed, 37
Considerations for drug trials in hypertrophic cardiomyopathy.
Farrant JP. et al, (2024), ESC Heart Fail
Cost-effectiveness of a novel AI technology to quantify coronary inflammation and cardiovascular risk in patients undergoing routine Coronary Computed Tomography Angiography.
Tsiachristas A. et al, (2024), Eur Heart J Qual Care Clin Outcomes
Feasibility of multiorgan risk prediction with routinely collected diagnostics: a prospective cohort study in the UK Biobank.
McCracken C. et al, (2024), BMJ Evid Based Med, 29, 313 - 323